720
Participants
Start Date
December 23, 2009
Primary Completion Date
January 15, 2014
Study Completion Date
November 27, 2015
PF-00299804
PF-804 45 mg PO, daily
Placebo
Placebo 45 mg PO, daily
Hospital Central De La Fuerza Aerea Del Peru, Lima
Tri-Service General Hospital, Taipei
China Medical University Hospital, Taichung
Chi-Mei Foundation Hospital, Tainan City
Phillippine General Hospital, Manila
Auckland City Hospital, Auckland
Makati Medical Center, Makati City
Prince of Wales Hospital, Randwick
Royal Prince Alfred Hospital, Camperdown
Royal North Shore Hospital, St Leonards
Concord Repatriation General Hospital, Concord
Westmead Hospital, Westmead
St. George Hospital, Cancer Care Centre, Kogarah
Calvary Mater Newcastle Hospital, Waratah
Western Hospital, Footscray
Austin Hospital, Heidelberg
Monash Medical Centre, Clayton
Frankston Hospital - Peninsula Oncology Centre, Frankston
Geelong Hospital, Geelong
The Prince Charles Hospital, Chermside
Nambour General Hospital, Nambour
Royal Adelaide Hospital, Adelaide
Perpetual Succour Hospital, Cebu City
Sir Charles Gairdner Hospital, Perth
Chulalongkorn University, Bangkok
Ramathibodi Hospital, Bangkok
Siriraj Hospital, Oncology Unit, Bangkok
U.O. di Oncologia Ospedale Villa Scassi, Genova
Ospedale San Raffaele, Milan
A.O. Busto Arsizio - P.O. Saronno, Saronno
Ospedale E. Morelli-Sondalo, Sondalo
Azienda USL di Piacenza, Ospedale Gugliemimo Salieto, Piacenza
U.O.C. di Oncologia U.L.S.S. 13, Mirano
Centro di Riferimento Oncologico - CRO, Aviano
UOC Oncologia Medica II Instituto Oncologio Veneto, Padua
Intstituto Scientifico Romangnolo, Meldola
Maharaj Nakorn Chiangmai Hospital, Chiang Mai
Clintell, Inc., Skokie
Ospedale Santa Croce, Fano
Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo
Dott. Fortunato Ciardiello,Cattedra Oncologia Medica, Napoli
Unita Sperimentazioni Cliniche Istituto per lo, Napoli
U.O. di Oncologia Medica Azienda Ospedaliera G Rummo, Benevento
Shapiro, Stafford and Yee, Arcadia
U.O.C. Terapie Integrate in Oncologia,, Messina
U.O.C. Oncologia Medica,, Messina
CER - Instituto Medico, Buenos Aires
Damic-Fundacion Rusculleda, Córdoba
La Maddalena, Dipartimento Oncologico, Palermo
Hospital Nacional Luis N. Saenz, Lima
Instituto de Oncologia y Radioterapia de, Lima
COIBA Centro de Oncologia e Investigacion, Berazategui
Centro Medico San Roque, San Miguel de Tucumán
Centro de Oncologia e Radioterapia (COR) Mae de Deus, Porto Alegre
Fundacao Pio XII - Hospital de Cancer de Barretos, Barretos
ESHO - Empresa de Servicos Hospitalares Ltda., Brasilia
Centro de Pesquisa Clinica do Hospital, Porto Alegre
Oxion Hospital Dia Oncologia LTDA - Oxion, Belo Horizonte
Centro
Nucleo de Oncologia da Bahia, Salvador
GRAM - Grupo de Assistencia Medica, São Paulo
Cross Cancer Institute, Edmonton
BCCA - Abbotsford Centre, Abbotsford
BCCA - Fraser Valley Cancer Centre, Surrey
BCCA - Vancouver Cancer Centre, Vancouver
Atlantic Health Sciences Corporation, Saint John
Dr. H. Bliss Murphy Cancer Centre, St. John's
QEII Health Sciences Centre, Halifax
Health Sciences North, Greater Sudbury
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
Cancer Centre of Southeastern Ontario at Kingston, Kingston
London Regional Cancer Program, London
Lakeridge Health Oshawa, Oshawa
Ottawa Health Research Institute - General Division, Ottawa
Algoma District Cancer Program, Sault Ste. Marie
Niagara Health System, St. Catharines
Univ. Health Network-Princess Margaret Hospital, Toronto
Windsor Regional Cancer Centre, Windsor
CHUM - Hopital Notre-Dame, Montreal
McGill University - Dept. Oncology, Montreal
Allan Blair Cancer Centre, Regina
Saskatoon Cancer Centre, Saskatoon
Azienda Ospedaliera S. Camillo-Forlanin, Rome
Policlinico Umberto I, Universita Sapienza, Rome
Ajou University Hospital, Gyeonggi-do
Chonnan National University Hwasun Hospital, Jeongnam
Yonsei University College of Medicine, Seoul
Seoul Veterans Hospital, Seoul
The Catholic University of Korea,, Seoul
Lead Sponsor
Collaborators (1)
Pfizer
INDUSTRY
NCIC Clinical Trials Group
NETWORK